|
|
 |
| MACS® GMP Recombinant Human IL-1β |
|
| Overview |
Interleukin-1β (IL-1β) is a pro-inflammatory cytokine that mediates inflammatory responses and displays a wide variety of biological activities on many different cell types, including T cells, B cells, and monocytes.
MACS GMP Recombinant Human IL-1β is designed for ex vivo cell culture processing. No animal- or human-derived materials were used for manufacture of this product. The product is lyophilized without carrier protein or preservatives. |
| Details |
Background information
IL-1β is mainly secreted by monocytes and macrophages. IL-1β secretion has also been reported for a variety of other cells, including B cells, NK cells, dendritic cells, astrocytes, and microglial cells. IL-1β acts also on nonimmune system cells such as fibroblasts, vascular endothelial cells, and hepatocytes.
Applications
MACS GMP Recombinant Human Interleukin 1β can be used for a variety of applications, including the ex vivo generation of human dendritic cells from enriched CD14+ monocyte populations.1-3
Quality statement
MACS GMP Products are manufactured and tested under a certified ISO 9001 quality system and in compliance with relevant GMP guidelines. They are designed following the recommendations of USP <1043> on ancillary materials.
A lot-specific certificate of analysis is provided, confirming identity, molecular mass, specific activity, sterility, purity, endotoxin content, and host-cell DNA content. |
| Disclaimer |
| MACS GMP Products are for research use and ex vivo cell culture processing only, and are not intended for human in vivo applications. |
| | |
|
|
| Favorites / Prices |
Request prices or add products to your favorite list.
|
| Details |
|
| Products |
| MACS GMP Recombinant Human IL-1β |
| Availability: Worldwide (1) |
| Source: E. coli |
- 25 μg
Download datasheet
170-076-102
|
| (1) For availability in your country please contact your local representative. |
|
| References |
| 1. Bender et al. (1996) J. Immunol. Methods 196: 121–135. |
| 2. Romani et al. (1996) J. Immunol. Methods 196: 137–151. |
| 3. Jonuleit et al. (1997) Eur. J. Immunol. 27: 3135–3142. |
|
|
|
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
|
